The largest database of trusted experimental protocols

Sas version 9.1 or higher

Manufactured by SAS Institute
Sourced in United States

SAS version 9.1 or higher is a software package for data analysis and statistical modeling. It provides a suite of tools for data management, statistical analysis, and reporting. The software is designed to work with a variety of data sources and can be used for tasks such as descriptive statistics, regression analysis, and multivariate techniques.

Automatically generated - may contain errors

Lab products found in correlation

7 protocols using sas version 9.1 or higher

1

Statistical Analysis of Diagnostic Assessments

Check if the same lab product or an alternative is used in the 5 most similar protocols
Descriptive statistics (n, mean, standard deviation) were calculated for
quantitative variables along with t-tests where appropriate; frequency counts by
category were to be given for qualitative variables along with Fisher’s exact
test where appropriate. Confidence intervals (CIs) were to be given where
appropriate. If not otherwise stated, these intervals are 2-sided in each case
and provide 95% confidence. Missing values were not replaced in the analysis of
efficacy. The sensitivities and specificities and respective 95% CIs for the
total population and 3 subgroups were calculated as average across the
assessments of 3 blinded readers taking into account the correlation between
multiple measurements (readers and segments) within the patient using an
extension of the approach by Obuchowski16 (link) as described in Schwenke and Busse.17 (link) Significance of differences was regarded if the 95% CIs for differences
did not overlap zero.
All analyses were performed using SAS Version 9.1 or higher (SAS Institute, Inc.,
Cary, NC, USA).
+ Open protocol
+ Expand
2

Statistical Analysis of Clinical Trial

Check if the same lab product or an alternative is used in the 5 most similar protocols
Student’s t-test or the Mann–Whitney U test were used for continuous variables, and the χ2 test was used for categorical data. PFS was calculated using the Kaplan–Meier method. SAS version 9.1 or higher (SAS Institute Inc., Cary, NC, USA) was used for all statistical analysis.
+ Open protocol
+ Expand
3

Integrated Analysis of Lumbar and Indwelling Catheter Studies

Check if the same lab product or an alternative is used in the 5 most similar protocols
The data were combined for an integrated analysis of the lumbar sample studies and from the indwelling catheter studies. Because each study and research group had different methods of sample collection, volume collected, and ELISAs, the data were transformed to a percentage of the mean in order to minimize the effects of the various extraneous factors. The data transformation was computed separately for Aβ40 and Aβ42.
It is well known that CSF amyloid concentrations are log-normally distributed [32 (link)] and all sample results were log-transformed. For the lumbar puncture results, the difference between the endpoint result and the baseline result was used as the primary response variable. For the repeated samples taken over 10–40 hours of indwelling catheter sampling, the concentrations were log-transformed and the mean concentration for each subject was computed. The difference from the mean concentration at each sampling time for each subject was computed. The differences were back-transformed and multiplied by 100 to obtain the percent concentration of the mean for each sample. The percent of the mean was used as the primary response variable.
All statistical programming and analysis was conducted in SAS version 9.1 or higher (SAS Institute Inc., Cary, NC, USA). The main statistical method used was the mixed procedure in SAS.
+ Open protocol
+ Expand
4

Statistical Analysis of Clinical Outcomes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Student’s t-test and the Mann–Whitney U-test were used to evaluate parametric and non-parametric continuous variables, respectively, and the chi-square test was used for categorical data. PFS was calculated using the Kaplan–Meier method, and statistical significance was analysed by the log-rank test unless otherwise specified. SAS version 9.1 or higher (SAS Institute Inc., Cary, NC, USA) was used for all statistical analyses.
+ Open protocol
+ Expand
5

Insulin Therapy Lipid Profile Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Statistical software used was SAS version 9.1 or higher (SAS Institute Inc. Cary, NC, USA). Analyses were conducted on all randomized patients in the lipid substudy who took at least one dose of study insulin. A mixed-model repeated measures (MMRM) model was used to analyze continuous variables collected at multiple post-treatment time points with terms for treatment, baseline values of the analysis variables, stratification factors for randomization, week, and treatment by week interactions. Values are presented as least squares mean (LSM) ± standard error (SE) unless otherwise noted. All treatment differences are reported as LSM difference (BIL-glargine) with 95% confidence intervals (CI). For treatment comparison at baseline, an analysis of variance model was used for continuous variables and Fisher’s exact test for categorical outcomes. Spearman’s correlation analyses were performed to assess the relationships between NMR parameters and LFC. To adjust for multiplicity, statistical significance is defined as two-sided p value <0.001. Raw data was analyzed as it was collected without transformation or exclusion of outliers. Missing data was handled through MMRM analysis without explicit imputation.
+ Open protocol
+ Expand
6

Pharmacokinetics and Safety Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The statistical software package used for efficacy and safety analyses was SAS, version 9.1 or higher (SAS Institute, NC, USA). Pharmacokinetics analyses were performed using Phoenix WinNonlin, version 6.2 (Certara, NJ, USA) or later.
Details as to target number of patients and sufficient statistical power are reported elsewhere [8] .
The rate of annualized SBIs for each patient was represented as point estimates with 99% CI, calculated as: r = (Total number of SBIs) / (Patient-years on study drug).
+ Open protocol
+ Expand
7

Exploratory Analysis of Efficacy and Safety

Check if the same lab product or an alternative is used in the 5 most similar protocols
Efficacy and safety outcomes were assessed. All comparisons were exploratory and descriptive. Interpretation of results was based on point estimates and their corresponding 95% confidence interval. Mean and 95% CI were calculated using the Poisson model to provide adjusted means (adjusted for baseline characteristics [region and age]). All statistical analyses were performed using SAS version 9.1 (or higher) software (SAS Institute Inc., Cary, NC, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!